Bouchaab, H.
43  Ergebnisse:
Personensuche X
?
 
?
 
?
5

125P A phase IIa study of the novel immunogenic cell death ..:

Imbimbo, M. ; Ghisoni, E. ; Mulvey, A....
Immuno-Oncology and Technology.  16 (2022)  - p. 100237 , 2022
 
?
6

Late-onset and long-lasting immune-related adverse events f..:

Ghisoni, E. ; Wicky, A. ; Bouchaab, H....
European Journal of Cancer.  149 (2021)  - p. 153-164 , 2021
 
?
7

Isodose 20 Gy found as a threshold dose for radiation recal..:

Scher, N. ; Vozenin, M.C. ; Bouchaab, H...
Clinical and Translational Radiation Oncology.  17 (2019)  - p. 14-16 , 2019
 
?
 
?
10

A PET-based nomogram for oropharyngeal cancers:

Castelli, J. ; Depeursinge, A. ; Ndoh, V....
European Journal of Cancer.  75 (2017)  - p. 222-230 , 2017
 
?
11

PV-0518: Phase 1 study of Debio 1143 in combination with Co..:

Tao, Y. ; Le Tourneau, C. ; Bouchaab, H....
Radiotherapy and Oncology.  119 (2016)  - p. S245-S246 , 2016
 
?
12

Stereotactic body radiotherapy with helical TomoTherapy for..:

Casutt, A ; Bouchaab, H ; Beigelman-Aubry, C...
The British Journal of Radiology.  88 (2015)  1049 - p. 20140687 , 2015
 
?
13

Helical Intensity Modulated Radiation Therapy With Daily Im..:

De Bari, B. ; Bouchaab, H. ; Péguret, N....
International Journal of Radiation Oncology*Biology*Physics.  90 (2014)  1 - p. S397-S398 , 2014
 
?
14

Carotid Dose Sparing in Definitive Irradiation of Early-Sta..:

Ozsahin, E. ; Cosinschi, A. ; Bouchaab, H....
International Journal of Radiation Oncology*Biology*Physics.  90 (2014)  1 - p. S534 , 2014
 
?
 
1-15